MODIFICATIONS IN THE ADVANCED IMMUNOLOGY 1 AND AUTOIMMUNITY PROGRAMS


 

In view of the need to develop control samples with a better reactivity, as established by the international standards, PNCQ decided to expand two advanced programs, since the presence of antibodies of several analytes in the same control sample hinders the existence of reactivity in some of them.

Therefore, the Advanced Immunology 1 and Autoimmunity Programs begin, from the batch of April 2018, to be expanded in the advanced programs related below:

EXPANSION OF THE IMMUNOLOGY 1 PROGRAM

-          Plasma proteins: C3, C4, IgA, IgG, IgM and IgE

-          Hepatitis B and C: HbsAg, Anti-HBe, Anti-HBs, Total Anti-HBc, Anti-HBcIgM, HBeAg, HCV

-          Infectious diseases: Mononucleosis, CMV IgG and IgM, Epstein Baar IgG and IgM, Toxoplasmosis IgG and IgM, Rubella IgG and IgM, Herpes IgG and IgM, HAV IgG and IgM

-          Rheumatic tests: C-reactive protein, Rheumatoid factor (Latex or Waaler Rose)

-          HTLV

-          HIV ½

EXPANSION OF THE AUTOIMMUNITY PROGRAM

-          Anti-CCP

-          Anti-Cardilipine IgA, IgG and IgM

-          Anti-DNA

-          Anti-Gliadin IgG and IgM

-          Anti-JO1

-          Anti-LKM1

-          Anti-Mitochondria

-          Anti-RNP and Anti-SM

-          Anti-SCL 70

-          Anti-SSA (RO) and Anti-SSB (La)

-          Anti-TPO and Anti-Thyroglobulin

-          Anti-ASCA IgG and IgM

-          Anti-PANCA and C-ANCA

The participating laboratories are already automatically registered in these programs. If you wish to evaluate the necessity of participation of your laboratory, get in touch with PNCQ within 30 days.



Published: 3/5/2018

Inscreva-se





Restricted Area